Why Enzo Biochem Inc : (XNYS:ENZ) can give you quick profits?

Why Enzo Biochem Inc : (XNYS:ENZ) can give you quick profits?

ByMarketFacts

Enzo Biochem, Inc. (XNYS:ENZ). is a biotechnology company that focuses on developing and commercializing innovative diagnostic and therapeutic products for clinical and research use. The company was founded in 1976 and is headquartered in New York City.

Enzo Biochem’s products and services are primarily focused on the life sciences and medical research markets. The company’s main areas of expertise include molecular biology, immunology, and cellular biology, and it offers a wide range of research reagents, assays, and platforms to support these areas. The company also develops and markets a variety of diagnostic products, including assays for infectious diseases, genetic disorders, and cancer, as well as immunohistochemistry and in situ hybridization products for pathology laboratories.

Bud to bloom:examining Aurora Cannabis’ (XTSE:ACB) rise in the industry

Bud to bloom:examining Aurora Cannabis’ (XTSE:ACB) rise in the industry

ByMarketFacts

Aurora Cannabis Inc. (XTSE: ACB) is a Canadian company that makes and sells cannabis for both medical and recreational use. Since it started in 2013, the company has grown to become one of the biggest cannabis producers in the world. Aurora sells dried flowers, oils, and edibles, among other things.
Aurora Cannabis is known for its focus on innovation and quality, as well as its commitment to using sustainable production methods. The company collaborates with a number of organizations, like universities and other research institutes, to make new products and learn more about how cannabis can be used as a medicine.

Is this clean energy producer stock worth a buy right now: Gevo Inc. (NASDAQ:GEVO)?

Is this clean energy producer stock worth a buy right now: Gevo Inc. (NASDAQ:GEVO)?

ByMarketFacts

Gevo Inc. (XNAS: GEVO) is a renewable chemicals and biofuel company that develops and commercializes alternatives to petroleum-based goods based on isobutanol derived from renewable feedstocks. Its operational segments include the Gevo sector, the Renewable Natural Gas segment, the Net-Zero segment, and the Agri-Energy business. It is engaged in research and development efforts linked to the future production of isobutanol, including developing its biocatalysts, manufacturing and selling biojet fuel, and creating biocatalysts. Gevo Development/Agri-Energy is the most important revenue-generating business, consisting of the operation of the Luverne Facility and the manufacture of ethanol, isobutanol, and associated products. 

Can this cancer- curing company provide relief to your portfolio: Y-mAbs Therapeutics Inc. (NASDAQ: YMAB)?

Can this cancer- curing company provide relief to your portfolio: Y-mAbs Therapeutics Inc. (NASDAQ: YMAB)?

ByMarketFacts

Y-mAbs Therapeutics Inc. (XNAS: YMAB), incorporated in 2015 and headquartered in New York is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel antibody-based therapeutic cancer products. In addition to conventional antibodies, the Company’s technologies include bispecific antibodies generated using the Y-BiClone platform and the SADA platform.

The Company’s broad and advanced product pipeline includes one FDA-approved product, DANYELZA, which targets tumors that express GD2, and one product candidate at the registration stage, OMBLASTYS, which targets tumors that express B7-H3.

With Douglas Elliman (NYSE: DOUG) going ex- dividend is there a room to get bullish on housing ?

With Douglas Elliman (NYSE: DOUG) going ex- dividend is there a room to get bullish on housing ?

ByMarketFacts

Douglas Elliman Inc. (XYNS: DOUG) is a real estate company. Among other real estate-related services, it provides sales, rentals, and new development in combination with mortgages and title insurance. The company operates in two divisions: Real Estate Brokerage and Corporate and Other. The company makes revenue from Commission and other brokerage income from existing house sales, Commission and other brokerage income from development marketing, Property management income, and Title fees. 

Shall Investors punt on this pharmaceutical penny stock: Avenue Therapeutics Inc. (NASDAQ: ATXI)?

Shall Investors punt on this pharmaceutical penny stock: Avenue Therapeutics Inc. (NASDAQ: ATXI)?

ByMarketFacts

Avenue Therapeutics (XNAS: ATXI) is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. Its mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc. Fortress is focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates.

Can Purple Innovation Inc Make your portfolio green (NASDAQ: PRPL) ?

Can Purple Innovation Inc Make your portfolio green (NASDAQ: PRPL) ?

ByMarketFacts

Purple Innovation Inc. (NASDAQ: PRPL) is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, pillows, cushions, sheets, bed platforms, and other products. Its proprietary gel technology, Hyper-Elastic Polymer, underpins many of the comfort products and provides a range of benefits that differentiate the offerings from other competitors’ products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.

Is it the right time to exit AeroClean Technologies Inc (NASDAQ: AERC) ?

Is it the right time to exit AeroClean Technologies Inc (NASDAQ: AERC) ?

ByMarketFacts

AeroClean Technologies, Inc. (NASDAQ: AERC) an interior space air purification technology company, provides air purification solutions for hospitals and other healthcare facilities. The company offers interior air sterilization and disinfection products for the eradication of harmful airborne pathogens, including COVID-19. It provides Pūrgo, an air sanitization product for indoor spaces; and Pūrgo Lift that provides air purification solution for elevators and other wall-mount applications. The company’s products use SteriDuct, a proprietary technology that safely optimizes UV exposure to effectively remove and destroy organic airborne pathogens.

Where is this air filtration technology stock heading: AeroClean Technologies Inc (NASDAQ: AERC )

Where is this air filtration technology stock heading: AeroClean Technologies Inc (NASDAQ: AERC )

ByMarketFacts

AeroClean Technologies, Inc. (NASDAQ: AERC) an interior space air purification technology company, provides air purification solutions for hospitals and other healthcare facilities. The company offers interior air sterilization and disinfection products for the eradication of harmful airborne pathogens, including COVID-19. It provides Pūrgo, an air sanitization product for indoor spaces; and Pūrgo Lift that provides air purification solution for elevators and other wall-mount applications. The company’s products use SteriDuct, a proprietary technology that safely optimizes UV exposure to effectively remove and destroy organic airborne pathogens.